|
|
OR |
95% CI |
p-val |
Model |
p-val |
I2
|
p-val (Egger’s
test)
|
Allelic model (del vs. ins) |
Allelic model (del
vs. ins) |
Allelic model (del vs. ins) |
|
|
|
|
|
|
Overall |
10 |
0.98 |
[0.8024; 1.1941] |
0.83 |
Random |
0.00 |
0.94 |
0.62 |
Type of cancer |
|
|
|
|
|
|
|
|
Colorectal |
2 |
1.04 |
[0.6035; 1.8090] |
0.88 |
Random |
0.00 |
0.97 |
NA |
Gastric |
2 |
0.78 |
[0.6916; 0.8701] |
0.00 |
Fixed |
0.20 |
0.40 |
NA |
Source of control |
|
|
|
|
|
|
|
|
HB |
7 |
0.99 |
[0.7614; 1.2833] |
0.93 |
Random |
0.00 |
0.94 |
0.62 |
PB |
3 |
0.95 |
[0.6606; 1.3705] |
0.79 |
Random |
0.00 |
0.95 |
0.87 |
Recessive model (del/del vs. del/ins+ ins/ins) |
Recessive model (del/del vs. del/ins+ ins/ins) |
Recessive model (del/del vs. del/ins+ ins/ins) |
Recessive model (del/del vs. del/ins+ ins/ins) |
Recessive model (del/del vs. del/ins+ ins/ins) |
|
|
|
|
Overall |
10 |
1.09 |
[0.7822; 1.5251] |
0.60 |
Random |
0.00 |
0.88 |
0.65 |
Type of cancer |
|
|
|
|
|
|
|
|
Colorectal |
2 |
1.14 |
[0.4599; 2.8040] |
0.78 |
Random |
0.00 |
0.95 |
NA |
Gastric |
2 |
0.73 |
[0.5565; 0.9603] |
0.02 |
Fixed |
0.43 |
0.00 |
NA |
Source of control |
|
|
|
|
|
|
|
|
HB |
7 |
1.14 |
[0.7453; 1.7457] |
0.54 |
Random |
0.00 |
0.88 |
0.75 |
PB |
3 |
0.99 |
[0.5133; 1.8995] |
0.97 |
Random |
0.00 |
0.92 |
0.69 |
Dominant model (del/del+ del/ins vs. ins/ins) |
Dominant model (del/del+ del/ins vs. ins/ins) |
Dominant model (del/del+ del/ins vs. ins/ins) |
Dominant model (del/del+ del/ins vs. ins/ins) |
Dominant model (del/del+ del/ins vs. ins/ins) |
|
|
|
|
Overall |
10 |
0.95 |
[0.7571; 1.2016] |
0.69 |
Random |
0.00 |
0.92 |
0.74 |
Type of cancer |
|
|
|
|
|
|
|
|
Colorectal |
2 |
1.04 |
[0.5500; 1.9623] |
0.91 |
Random |
0.00 |
0.96 |
NA |
Gastric |
2 |
0.73 |
[0.6278; 0.8404] |
0.00 |
Fixed |
0.29 |
0.09 |
NA |
Source of control |
|
|
|
|
|
|
|
|
HB |
7 |
0.97 |
[0.7099; 1.3132] |
0.82 |
Random |
0.00 |
0.92 |
0.68 |
PB |
3 |
0.92 |
[0.6108; 1.3874] |
0.69 |
Random |
0.00 |
0.93 |
0.97 |
Over-dominant model ( del/ins vs. del/del+ ins/ins) |
Over-dominant model ( del/ins vs. del/del+ ins/ins) |
Over-dominant model ( del/ins vs. del/del+ ins/ins) |
Over-dominant model ( del/ins vs. del/del+ ins/ins) |
Over-dominant model ( del/ins vs. del/del+ ins/ins) |
Over-dominant model ( del/ins vs. del/del+ ins/ins) |
|
|
|
Overall |
10 |
0.93 |
[0.8199; 1.0549] |
0.26 |
Random |
0.00 |
0.71 |
0.53 |
Type of cancer |
|
|
|
|
|
|
|
|
Colorectal |
2 |
0.98 |
[0.7166; 1.3284] |
0.88 |
Random |
0.01 |
0.85 |
NA |
Gastric |
2 |
0.79 |
[0.6809; 0.9161] |
0.00 |
Fixed |
0.45 |
0.00 |
NA |
Source of control |
|
|
|
|
|
|
|
|
HB |
7 |
0.93 |
[0.7830; 1.1127] |
0.44 |
Random |
0.00 |
0.75 |
0.47 |
PB |
3 |
0.91 |
[0.7521; 1.1032] |
0.34 |
Random |
0.04 |
0.70 |
0.95 |
Homozygote contrast model (del/del vs. ins/ins) |
Homozygote contrast model (del/del vs. ins/ins) |
Homozygote contrast model (del/del vs. ins/ins) |
Homozygote contrast model (del/del vs. ins/ins) |
Homozygote contrast model (del/del vs. ins/ins) |
|
|
|
|
Overall |
10 |
1.06 |
[0.6964; 1.6162] |
0.78 |
Random |
0.00 |
0.92 |
0.68 |
Type of cancer |
|
|
|
|
|
|
|
|
Colorectal |
2 |
1.15 |
[0.3629; 3.6704] |
0.81 |
Random |
0.00 |
0.97 |
NA |
Gastric |
2 |
0.64 |
[0.4861; 0.8529] |
0.00 |
Fixed |
0.38 |
0.00 |
NA |
Source of control |
|
|
|
|
|
|
|
|
HB |
7 |
1.11 |
[0.6484; 1.9116] |
0.70 |
Random |
0.00 |
0.92 |
0.76 |
PB |
3 |
0.94 |
[0.4190; 2.1301] |
0.89 |
Random |
0.00 |
0.94 |
0.74 |
Additive model (del/del vs. ins/del) |
Additive
model (del/del vs. ins/del) |
Additive model (del/del
vs. ins/del) |
Additive model (del/del vs.
ins/del) |
|
|
|
|
|
Overall |
10 |
1.15 |
[0.9055; 1.4682] |
0.25 |
Random |
0.00 |
0.74 |
0.74 |
Type of cancer |
|
|
|
|
|
|
|
|
Colorectal |
2 |
1.13 |
[0.5977; 2.1423] |
0.70 |
Random |
0.00 |
0.89 |
NA |
Gastric |
2 |
0.86 |
[0.6475; 1.1475] |
0.31 |
Fixed |
0.67 |
0.00 |
NA |
Source of control |
|
|
|
|
|
|
|
|
HB |
7 |
1.21 |
[0.8941; 1.6358] |
0.22 |
Random |
0.00 |
0.73 |
0.87 |
PB |
3 |
1.04 |
[0.6414; 1.6999] |
0.86 |
Random |
0.00 |
0.84 |
0.64 |
Heterozygote contrast model (del/ins vs. ins/ins) |
Heterozygote contrast model (del/ins vs. ins/ins) |
Heterozygote contrast model (del/ins vs. ins/ins) |
Heterozygote contrast model (del/ins vs. ins/ins) |
Heterozygote contrast model (del/ins vs. ins/ins) |
|
|
|
|
Overall |
10 |
0.94 |
[0.7744; 1.1403] |
0.53 |
Random |
0.00 |
0.87 |
0.69 |
Type of cancer |
|
|
|
|
|
|
|
|
Colorectal |
2 |
1.01 |
[0.6033; 1.7019] |
0.96 |
Random |
0.00 |
0.94 |
NA |
Gastric |
2 |
0.75 |
[0.6394; 0.8683] |
0.00 |
Fixed |
0.40 |
0.00 |
NA |
Source of control |
|
|
|
|
|
|
|
|
HB |
7 |
0.95 |
[0.7299; 1.2315] |
0.69 |
Random |
0.00 |
0.88 |
0.62 |
PB |
3 |
0.91 |
[0.6576; 1.2645] |
0.58 |
Random |
0.00 |
0.89 |
1.00 |